Leishmania major-specific B cells are necessary for Th2 cell development and susceptibility to L. major LV39 in BALB/c mice

Journal of Immunology

Volumn 180, Issue 7, 2008, Pages 4825-4835

  Ronet, Catherine ^a,b   Voigt, Heike ^a,b   Himmelrich, Hayo ^a,b   Doucey, Marie Agnès ^b,c   Torre, Yazmin Hauyon La ^a,b   Revaz Breton, Mélanie ^a,b   Tacchini Cottier, Fabienne ^a,b   Bron, Claude ^b   Louis, Jacques ^d   Launois, Pascal ^a,b  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c INSTITUT PASTEUR   (France)

^d Center for Integrative Genomics   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN D; IMMUNOGLOBULIN M; PROTOZOON ANTIBODY;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CELL MATURATION; CONTROLLED STUDY; DISEASE COURSE; INFECTION RESISTANCE; INFECTION SENSITIVITY; LEISHMANIA MAJOR; LEISHMANIASIS; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; TH2 CELL; ANIMAL; ANTIGEN PRESENTING CELL; BAGG ALBINO MOUSE; CELL CULTURE; CELL DIFFERENTIATION; DISEASE PREDISPOSITION; IMMUNOLOGY; INNATE IMMUNITY; SKIN LEISHMANIASIS;

ADOPTIVE TRANSFER; ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGEN-PRESENTING CELLS; B-LYMPHOCYTES; CELL DIFFERENTIATION; CELLS, CULTURED; DISEASE SUSCEPTIBILITY; IMMUNITY, NATURAL; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; MICE; MICE, INBRED BALB C; PHENOTYPE; TH2 CELLS;

EID: 44449097726     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.7.4825     Document Type: Article

References (56)

1. Chesnut, R. W., and H. M. Grey. 1981. Studies on the capacity of B cells to serve as antigen-presenting cells. J. Immunol. 126: 1075-1079.
2. Rock, K. L., B. Benacerraf, and A. K. Abbas. 1984. Antigen presentation by hapten-specific B lymphocytes. I. Role of surface immunoglobulin receptors. J. Exp. Med. 160: 1102-1113.
3. Krieger, J. I., S. F. Grammer, H. M. Grey, and R. W. Chesnut. 1985. Antigen presentation by splenic B cells: resting B cells are ineffective, whereas activated B cells are effective accessory cells for T cell responses. J. Immunol. 135:2937-2945.
4. Kakiuchi, T., R. W. Chesnut, and H. M. Grey. 1983. B cells as antigen-presenting cells: the requirement for B cell activation. J. Immunol 131: 109-114.
5. + T cell priming in vivo. J. Immunol. 162: 5695-5703.
6. Gajewski, T. F., M. Pinnas, T. Wong, and F. W. Fitch. 1991. Murine Th1 and Th2 clones proliferate optimally in response to distinct antigen-presenting cell populations. J. Immunol. 146: 1750-1758.
7. Ron, Y., and J. Sprent. 1987. T cell priming in vivo: a major role for B cells in presenting antigen to T cells in lymph nodes. J. Immunol. 138: 2848-2856.
8. Ron, Y., P. De Baetselier, J. Gordon, M. Feldman, and S. Segal. 1981. Defective induction of antigen-reactive proliferating T cells in B cell-deprived mice. Eur. J. Immunol. 11: 964-968.
9. Janeway, C. A., Jr., J. Ron, and M. E. Katz. 1987. The B cell is the initiating antigen-presenting cell in peripheral lymph nodes. J. Immunol. 138: 1051-1055.
10. Epstein, M. M., F. Di Rosa, D. Jankovic, A. Sher, and P. Matzinger. 1995. Successful T cell priming in B cell-deficient mice. J. Exp. Med. 182: 915-922.
11. + T cell activation and tolerance induction in B cell knockout mice. J. Exp. Med. 183: 1339-1344.
12. HD mice fail to provide B cell help. J. Immunol. 160:1694-1700.
13. Reiner, S. L., and R. M. Locksley. 1995. The regulation of immunity to Leishmanial major. Annu. Rev. Immunol. 13: 151-177.
14. Sacks, D. L., P. A. Scott, R. Asofsky, and F. A. Sher. 1984. Cutaneous leishmaniasis in anti-IgM-treated mice: enhanced resistance due to functional depletion of a B cell-dependent T cell involved in the suppressor pathway. J. Immunol. 132: 2072-2077.
15. Hoerauf, A., W. Solbach, M. Lohoff, and M. Rollinghoff. 1994. The Xid defect determines an improved clinical course of murine leishmaniasis in susceptible mice. Int. Immunol. 6: 1117-1124.
16. Hoerauf, A., W. Solbach, M. Rollinghoff, and A. Gessner. 1995. Effect of IL-7 treatment on Leishmania major-infected BALB.Xid mice: enhanced lymphopoiesis with sustained lack of B1 cells and clinical aggravation of disease. Int. Immunol. 7: 1879-1884.
17. Hoerauf, A., M. Rollinghoff, and W. Solbach. 1996. Co-transfer of B cells converts resistance into susceptibility in T cell-reconstituted, Leishmania major-resistant C.B-17 scid mice by a non-cognate mechanism. Int. Immunol. 8:1569-1575.
18. Rossi-Bergmann, B., I. Muller, and E. B. Godinho. 1993. TH1 and TH2 T-cell subsets are differentially activated by macrophages and B cells in murine leish-maniasis. Infect. Immun. 61: 2266-2269.
19. Brown, D. R., and S. L. Reiner. 1999. Polarized helper-T-cell responses against Leishmania major in the absence of B cells. Infect. Immun. 67: 266-270.
20. Colmenares, M., S. L. Constant, P. E. Kima, and D. McMahon-Pratt. 2002. Leish-mania pifanoi pathogenesis: selective lack of a local cutaneous response in the absence of circulating antibody. Infect. Immun. 70: 6597-6605.
21. Miles, S. A., S. M. Conrad, R. G. Alves, S. M. Jeronimo, and D. M. Mosser. 2005. A role for IgG immune complexes during infection with the intracellular pathogen Leishmania. J. Exp. Med. 201: 747-754.
22. Kitamura, D., J. Roes, R. Kuhn, and K. Rajewsky. 1991. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature 350: 423-426.
23. Hartley, S. B., M. P. Cooke, D. A. Fulcher, A. W. Harris, S. Cory, A. Basten, and C. C. Goodnow. 1993. Elimination of self-reactive B lymphocytes proceeds in two stages: arrested development and cell death. Cell 72: 325-335.
24. Reiner, S. L., D. J. Fowell, N. H. Moskowitz, K. Swier, D. R. Brown, C. R. Brown, C. W. Turck, P. A. Scott, N. Killeen, and R. M. Locksley. 1998. Control of Leishmania major by a monoclonal αβ T cell repertoire. J. Immunol. 160: 884-889.
25. Louis, J., E. Moedder, R. Behin, and H. Engers. 1979. Recognition of protozoan parasite antigens by murine T lymphocytes. I. Induction of specific T lymphocyte-dependent proliferative response to Leishmania tropica. Eur. J. Immunol. 9:841-847.
26. + T cells instructs Th2 development and susceptibility to Leishmania major in BALB/c mice. Immunity 6: 541-549.
27. Kima, P. E., S. L. Constant, L. Hannum, M. Colmenares, K. S. Lee, A. M. Haberman, M. J. Shlomchik, and D. McMahon-Pratt. 2000. Internalization of Leishmania mexicana complex amastigotes via the Fc receptor is required to sustain infection in murine cutaneous leishmaniasis. J. Exp. Med. 191:1063-1068.
28. Slade, S. J., and J. Langhorne. 1989. Production of interferon-γ during infection of mice with Plasmodium chabaudi chabaudi. Immunobiology 179: 353-365.
29. + T cells by HLA-DR1 oligomers is dependent on the T cell activation state. J. Immunol. 166: 741-745.
30. Reiner, S. L., S. Zheng, D. B. Corry, and R. M. Locksley. 1993. Constructing polycompetitor cDNAs for quantitative PCR. J. Immunol. Methods 165: 37-46.
31. Smelt, S. C., S. E. Cotterell, C. R. Engwerda, and P. M. Kaye. 2000. B cell-deficient mice are highly resistant to Leishmania donovani infection, but develop neutrophil-mediated tissue pathology. J. Immunol. 164: 3681-3688.
32. Noben-Trauth, N., W. E. Paul, and D. L. Sacks. 1999. IL-4-and IL-4 receptor-deficient BALB/c mice reveal differences in susceptibility to Leishmania major parasite substrains. J. Immunol. 162: 6132-6140.
33. Noben-Trauth, N., R. Lira, H. Nagase, W. E. Paul, and D. L. Sacks. 2003. The relative contribution of IL-4 receptor signaling and IL-10 to susceptibility to Leishmania major. J. Immunol. 170: 5152-5158.
34. Kane, M. M., and D. M. Mosser. 2001. The role of IL-10 in promoting disease progression in leishmaniasis. J. Immunol. 166: 1141-1147.
35. Mosser, D. M., and L. A. Rosenthal. 1993. Leishmania-macrophage interactions: multiple receptors, multiple ligands and diverse cellular responses. Semin. Cell. Biol. 4: 315-322.
36. Peters, C., T. Aebischer, Y. D. Stierhof, M. Fuchs, and P. Overath. 1995. The role of macrophage receptors in adhesion and uptake of Leishmania mexicana amas-tigotes. J. Cell Sci. 108: 3715-3724.
37. Hayglass, K. T., S. J. Naides, C. F. Scott, Jr., B. Benacerraf, and M. S. Sy. 1986. T cell development in B cell-deficient mice. IV. The role of B cells as antigen-presenting cells in vivo. J. Immunol. 136: 823-829.
38. Kurt-Jones, E. A., D. Liano, K. A. HayGlass, B. Benacerraf, M. S. Sy, and A. K. Abbas. 1988. The role of antigen-presenting B cells in T cell priming in vivo: studies of B cell-deficient mice. J. Immunol. 140: 3773-3778.
39. Liu, Y., Y. Wu, L. Ramarathinam, Y. Guo, D. Huszar, M. Trounstine, and M. Zhao. 1995. Gene-targeted B-deficient mice reveal a critical role for B cells in the CD4 T cell response. Int. Immunol. 7: 1353-1362.
40. Sugie, K., and J. Huang. 2001. GIF inhibits Th effector generation by acting on antigen-presenting B cells. J. Immunol. 166: 4473-4480.
41. Klinman, N. R., and J. L. Press. 1975. The B cell specificity repertoire: its relationship to definable subpopulations. Transplant. Rev. 24: 41-83.
42. Liu, Y. J., J. Zhang, P. J. Lane, E. Y. Chan, and I. C. MacLennan. 1991. Sites of specific B cell activation in primary and secondary responses to T cell-dependent and T cell-independent antigens. Eur. J. Immunol. 21: 2951-2962.
43. Pape, K. A., D. M. Catron, A. A. Itano, and M. K. Jenkins. 2007. The humoral immune response is initiated in lymph nodes by B cells that acquire soluble antigen directly in the follicles. Immunity 26: 491-502.
44. Sadick, M. D., F. P. Heinzel, B. J. Holaday, R. T. Pu, R. S. Dawkins, and R. M. Locksley. 1990. Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody: evidence for a T cell-dependent, interferon γ-independent mechanism. J. Exp. Med. 171: 115-127.
45. Harris, D. P., L. Haynes, P. C. Sayles, D. K. Duso, S. M. Eaton, N. M. Lepak, L. L. Johnson, S. L. Swain, and F. E. Lund. 2000. Reciprocal regulation of polarized cytokine production by effector B and T cells. Nat. Immunol. 1:475-482.
46. Stockinger, B., T. Zal, A. Zal, and D. Gray. 1996. B cells solicit their own help from T cells. J. Exp. Med. 183: 891-899.
47. + T cells to produce IL-4. J. Immunol. 158: 4171-4179.
48. Liu, Q., Z. Liu, C. T. Rozo, H. A. Hamed, F. Alem, J. F. Urban, Jr., and W. C. Gause. 2007. The role of B cells in the development of CD4 effector T cells during a polarized Th2 immune response. J. Immunol. 179: 3821-3830.
49. Morris, S. C., A. Lees, and F. D. Finkelman. 1994. In vivo activation of naive T cells by antigen-presenting B cells. J. Immunol. 152: 3777-3785.
50. Rivera, A., C. C. Chen, N. Ron, J. P. Dougherty, and Y. Ron. 2001. Role of B cells as antigen-presenting cells in vivo revisited: antigen-specific B cells are essential for T cell expansion in lymph nodes and for systemic T cell responses to low antigen concentrations. Int. Immunol. 13: 1583-1593.
51. Ronchese, F., and B. Hausmann. 1993. B lymphocytes in vivo fail to prime naive T cells but can stimulate antigen-experienced T lymphocytes. J. Exp. Med. 177:679-690.
52. Wykes, M., A. Pombo, C. Jenkins, and G. G. MacPherson. 1998. Dendritic cells interact directly with naive B lymphocytes to transfer antigen and initiate class switching in a primary T-dependent response. J. Immunol. 161: 1313-1319.
53. Qi, H., J. G. Egen, A. Y. Huang, and R. N. Germain. 2006. Extrafollicular activation of lymph node B cells by antigen-bearing dendritic cells. Science 312:1672-1676.
54. Garside, P., E. Ingulli, R. R. Merica, J. G. Johnson, R. J. Noelle, and M. K. Jenkins. 1998. Visualization of specific B and T lymphocyte interactions in the lymph node. Science 281: 96-99.
55. Banchereau, J., F. Briere, C. Caux, J. Davoust, S. Lebecque, Y. J. Liu, B. Pulendran, and K. Palucka. 2000. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18: 767-811.
56. + T cells. J. Exp. Med. 185:2133-2141.